apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Lanzira 15 mg Orally Disintegrating Tablet

  3. Lanzira 15 mg Orally Disintegrating Tablet Substitute

Lanzira 15 mg Orally Disintegrating Tablet Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

LANSOPRAZOLE-15MG

Uses:

Lanzira 15 mg Orally Disintegrating Tablet is used in the treatment of Gastro-oesophageal reflux disease, erosive esophagitis, and Zollinger-Ellison syndrome. The detailed uses of Lanzira 15 mg Orally Disintegrating Tablet are as follows:<br/>• Gastroesophageal Reflux Disease (GERD): Lanzira 15 mg Orally Disintegrating Tablet helps reduce acid reflux symptoms such as heartburn, regurgitation, and chest discomfort by lowering stomach acid production. It promotes healing of the esophagus in children with chronic acid exposure.<br/>• Peptic Ulcer Disease: Lanzira 15 mg Orally Disintegrating Tablet is used to treat ulcers in the stomach or upper part of the small intestine (duodenum). It supports ulcer healing by reducing acid levels and protecting the stomach lining.<br/>• Zollinger-Ellison Syndrome: Lanzira 15 mg Orally Disintegrating Tablet may be prescribed in rare cases where the stomach produces excessive acid due to tumors. It helps control acid output and prevents complications like ulcers and bleeding.<br/>• NSAID-Induced Gastric Ulcers: Lanzira 15 mg Orally Disintegrating Tablet is used to prevent or treat ulcers caused by long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs), especially in children who require pain management for chronic conditions.<br/>• Stress Ulcers and Acid-Related Indigestion: Lanzira 15 mg Orally Disintegrating Tablet can be used in hospitalized or critically ill children to prevent stress-related mucosal damage and reduce symptoms like bloating, nausea, and upper abdominal pain.<br/>

Medicinal Benefits:

Lanzira 15 mg Orally Disintegrating Tablet belongs to a group of antiulcer medicines called 'proton pump inhibitors' indicated in the treatment of gastroesophageal reflux disease, erosive esophagitis, and Zollinger Ellison syndrome. It is also used to prevent and treat ulcers of the oesophagus. Lanzira 15 mg Orally Disintegrating Tablet contains 'Lansoprazole', which works by blocking the action of an enzyme known as the gastric proton pump responsible for the production of acid. This helps reduce the symptoms of heartburn and reflux and promotes the healing of ulcers.

FAQs

Lanzira 15 mg Orally Disintegrating Tablet is used to treat gastroesophageal reflux disease, erosive esophagitis, and Zollinger-Ellison syndrome. It is also used to prevent and treat ulcers of the oesophagus.

Lanzira 15 mg Orally Disintegrating Tablet works by blocking the action of an enzyme known as the gastric proton pump responsible for the production of acid. This helps in reducing the symptoms of heartburn, reflux and promotes the healing of ulcers

Lanzira 15 mg Orally Disintegrating Tablet may cause swelling and itchiness of the fingers and toes. Try applying an anti-itch cream or a moisturising cream. If the condition persists after two weeks, consult your doctor.

You are advised to maintain a gap of two hours between Lanzira 15 mg Orally Disintegrating Tablet and indigestion medicines. However, please consult a doctor before giving indigestion/antacid medicines along with Lanzira 15 mg Orally Disintegrating Tablet to the child.